ArticleO&G open2026
Prenatal Remote Blood Pressure Monitoring and Detection of Chronic Hypertension.
Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate whether universal enrollment in a prenatal remote blood pressure (BP) monitoring program initiated at the first prenatal visit is associated with higher rates of new chronic hypertension diagnosis before 20 weeks of gestation compared with usual care.
methodsThis was a retrospective cohort study comparing patients enrolled and those not enrolled in the remote BP monitoring intervention between September 2021 and May 2023. Two:one optimal pair propensity score matching balanced nine demographic and clinical covariates between groups. A logistic regression model with remote BP monitoring enrollment as the sole independent variable estimated the odds of chronic hypertension diagnosis within 20 weeks; cluster-robust SEs accounted for within-pair dependence. Odds ratios (ORs) with 95% CIs and average predicted probabilities were reported.
resultsOf 3,294 patients initially included (508 remote BP monitoring, 2,786 usual care), 1,521 remained after 2:1 matching (507 remote BP monitoring, 1,014 usual care). Remote BP monitoring patients had 68.0% higher odds of chronic hypertension diagnosis (OR 1.68, 95% CI, 1.10-2.57,
conclusionUniversal prenatal remote BP monitoring is associated with significantly higher odds of chronic hypertension diagnosis before 20 weeks compared with propensity score-matched controls, enabling timely chronic hypertension-specific management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.